Agenus Inc (AGEN)
12.35
+0.44
(+3.69%)
USD |
NASDAQ |
May 23, 16:00
12.37
+0.02
(+0.16%)
After-Hours: 20:00
Agenus Total Return Level: 12.35 for May 23, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 23, 2024 | 12.35 |
May 22, 2024 | 11.91 |
May 21, 2024 | 11.12 |
May 20, 2024 | 10.70 |
May 17, 2024 | 10.86 |
May 16, 2024 | 10.50 |
May 15, 2024 | 10.78 |
May 14, 2024 | 10.70 |
May 13, 2024 | 11.09 |
May 10, 2024 | 10.49 |
May 09, 2024 | 11.72 |
May 08, 2024 | 11.47 |
May 07, 2024 | 12.01 |
May 06, 2024 | 12.95 |
May 03, 2024 | 13.07 |
May 02, 2024 | 12.52 |
May 01, 2024 | 13.26 |
April 30, 2024 | 12.12 |
April 29, 2024 | 12.76 |
April 26, 2024 | 11.69 |
April 25, 2024 | 8.30 |
April 24, 2024 | 7.42 |
April 23, 2024 | 6.46 |
April 22, 2024 | 5.77 |
April 19, 2024 | 5.31 |
Date | Value |
---|---|
April 18, 2024 | 4.97 |
April 17, 2024 | 5.40 |
April 16, 2024 | 6.30 |
April 15, 2024 | 6.50 |
April 12, 2024 | 8.15 |
April 11, 2024 | 8.87 |
April 10, 2024 | 8.922 |
April 09, 2024 | 9.73 |
April 08, 2024 | 9.31 |
April 05, 2024 | 10.07 |
April 04, 2024 | 10.12 |
April 03, 2024 | 10.60 |
April 02, 2024 | 10.24 |
April 01, 2024 | 11.75 |
March 28, 2024 | 11.60 |
March 27, 2024 | 11.13 |
March 26, 2024 | 10.73 |
March 25, 2024 | 11.17 |
March 22, 2024 | 10.92 |
March 21, 2024 | 11.24 |
March 20, 2024 | 11.09 |
March 19, 2024 | 11.25 |
March 18, 2024 | 10.59 |
March 15, 2024 | 10.80 |
March 14, 2024 | 11.99 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
4.97
Minimum
Apr 18 2024
130.05
Maximum
Aug 30 2021
54.46
Average
52.77
Median
Jul 05 2019
Total Return Level Benchmarks
Ligand Pharmaceuticals Inc | 119.04 |
Protalix BioTherapeutics Inc | 1.18 |
InfuSystems Holdings Inc | 6.92 |
PAVmed Inc | 1.65 |
Allogene Therapeutics Inc | 2.54 |